CONTI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 3.648
EU - Europa 2.006
AS - Asia 1.157
AF - Africa 160
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 6.980
Nazione #
US - Stati Uniti d'America 3.633
GB - Regno Unito 577
CN - Cina 439
SE - Svezia 360
SG - Singapore 312
IT - Italia 303
DE - Germania 244
VN - Vietnam 232
IN - India 105
IE - Irlanda 99
RU - Federazione Russa 92
FR - Francia 71
TG - Togo 62
UA - Ucraina 54
EE - Estonia 51
ZA - Sudafrica 46
JO - Giordania 34
CH - Svizzera 32
BG - Bulgaria 31
BE - Belgio 30
CI - Costa d'Avorio 27
NG - Nigeria 24
NL - Olanda 17
AT - Austria 15
CA - Canada 12
IR - Iran 11
FI - Finlandia 9
HK - Hong Kong 5
ID - Indonesia 5
BR - Brasile 3
CZ - Repubblica Ceca 3
HR - Croazia 3
LB - Libano 3
MK - Macedonia 3
PL - Polonia 3
TR - Turchia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
DK - Danimarca 2
JP - Giappone 2
PT - Portogallo 2
AZ - Azerbaigian 1
BB - Barbados 1
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
GL - Groenlandia 1
IL - Israele 1
IQ - Iraq 1
MX - Messico 1
NO - Norvegia 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
TW - Taiwan 1
Totale 6.980
Città #
Fairfield 537
Southend 536
Chandler 385
Singapore 277
Ashburn 255
Houston 229
Woodbridge 218
Seattle 210
Wilmington 194
Ann Arbor 179
Dong Ket 154
Cambridge 153
Santa Clara 147
Princeton 119
Dublin 99
Boardman 94
Bologna 82
Nanjing 67
Lomé 62
Westminster 53
Padova 43
New York 38
Amman 34
San Diego 32
Berlin 30
Brussels 30
Jinan 30
Sofia 29
Bern 28
Saint Petersburg 28
Abidjan 27
Bremen 27
Beijing 25
Abeokuta 24
Florence 24
Jacksonville 24
Turin 24
Tianjin 21
Shenyang 20
Guangzhou 18
Nanchang 18
Redmond 17
Dearborn 16
Medford 15
Milan 15
Falls Church 13
Vienna 12
Changsha 11
Hebei 11
Des Moines 9
Haikou 9
Helsinki 9
Los Angeles 9
Toronto 9
Shanghai 8
Wuhan 8
Chicago 7
Fuzhou 7
Zhengzhou 7
Groningen 6
Hangzhou 6
Lanzhou 6
London 6
Moscow 6
Amsterdam 5
Jiaxing 5
Redwood City 5
Rome 5
Saint Louis 5
Xi'an 5
Ardabil 4
Buffalo 4
Frankfurt Am Main 4
Jakarta 4
Kunming 4
Leawood 4
Lucca 4
Monmouth Junction 4
Mountain View 4
Ningbo 4
Norwalk 4
Olalla 4
Paris 4
Phoenix 4
Provo 4
Sacramento 4
Stockholm 4
Suzhou 4
Taizhou 4
Benevento 3
Boydton 3
Bühl 3
Hong Kong 3
Hyderabad 3
La Spezia 3
Pisa 3
Qingdao 3
Skopje 3
Taiyuan 3
Washington 3
Totale 4.985
Nome #
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 222
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography 207
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 180
Alcohol and viral hepatitis: a mini-review. 172
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 160
Treating hepatitis C in the elderly: the future is near? 152
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 151
Point quantification elastography in the evaluation of liver elasticity in healthy volunteers: a reliability study based on operator expertise 150
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study. 150
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 146
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. 146
Monofocal hepatocellular carcinoma: How much does size matter? 140
Chronic hepatitis B: Are we close to a cure? 137
Correlation Between Renal Cortical Stiffness and Histological Determinants by Point Shear-Wave Elastography in Patients With Kidney Transplantation 136
Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis 135
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 134
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 134
Vitamins in the treatment of chronic viral hepatitis. 133
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 130
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 127
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 127
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 126
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 124
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 123
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 118
Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study 117
DIAGNOSTIC ACCURACY OF LIVER AND SPLEEN STIFFNESS MEASUREMENT FOR PORTAL HYPERTENSION USING BIDIMENSIONAL SHEAR WEAVE ELASTOGRAPHY 116
A New Two-Dimensional Shear Wave Elastography for Noninvasive Assessment of Liver Fibrosis in Healthy Subjects and in Patients with Chronic Liver Disease - Eine neue zweidimensionale Shear-Wave-Elastografie zur nicht-invasiven Beurteilung der Leberfibrose bei Gesunden und bei Patienten mit chronischer Lebererkrankung 116
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 115
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 114
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 113
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 108
null 107
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study. 103
Bile salt export pump deficiency disease: Two novel, late onset, ABCB11 mutations identified by next generation sequencing 101
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 98
SP714SHEAR WAVE ELASTOGRAPHY IN KIDNEY TRANSPLANTATION: NONINVASIVE ALTERNATIVE TO ALLOGRAFT BIOPSY? 98
null 96
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 96
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 96
Liver Stiffness improvement in subjects with advanced chronic hepatitis C treated with direct antiviral agents. 95
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 95
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir? 94
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 93
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature 93
Liver AL amyloidosis as a possible cause of high liver stiffness values. 93
null 92
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy. 91
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness. 91
Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study 90
Liver AL amyloidosis as a possible cause of high liver stiffness values. 88
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection. 83
Hepatitis C in the elderly: a multicenter cross-sectional study by the Italian Association for the Study of the Liver. 78
Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals 72
null 70
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 70
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 70
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 68
IMPULSIONAL, POINT AND BIDIMENSIONAL SHEAR WAVE ELASTOMETRY FOR PORTAL HYPERTENSION: SAME STIFFNESS THRESHOLDS? 63
The changing scenario of hepatocellular carcinoma in Italy: an update 60
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 60
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 54
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 53
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 50
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 36
Totale 7.156
Categoria #
all - tutte 18.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.533


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020974 0 0 0 0 0 0 230 218 256 104 69 97
2020/2021855 152 75 37 18 9 33 22 45 90 59 40 275
2021/20221.329 119 40 67 82 102 56 19 79 35 128 398 204
2022/20231.478 135 214 72 234 98 130 51 76 245 33 114 76
2023/2024367 29 59 24 31 39 86 11 33 22 18 7 8
2024/2025845 64 230 116 129 215 73 18 0 0 0 0 0
Totale 7.156